Advertisement

Coccidioidomycosis

  • Gowtham Jonna
  • Anita Agarwal
Living reference work entry

Abstract

Coccidioidomycosis or the San Joaquin Valley fever is a granulomatous disease caused by the soil-dwelling dimorphic fungus Coccidioides immitis or Coccidioides posadasii. Ocular involvement typically occurs secondary to dissemination and is considered rare. The uvea is the most common site of intraocular disease. Coccidioidal uveitis should be considered in any patient with apparent idiopathic, granulomatous iridocyclitis, or choroiditis who has lived or traveled through endemic areas, including Arizona, New Mexico, west Texas, parts of Central America, Argentina, northwest Mexico, and the San Joaquin Valley in California. Skin and serologic testing confirm exposure to Coccidioidal antigen, but tissue biopsy is necessary for definitive diagnosis. Prompt recognition and treatment with systemic and local antifungal therapy is critical to save life, the eye, and potentially vision. Amphotericin B has proven efficacy but is limited by toxic adverse effects. Systemic and intravitreal azole therapy are efficacious against coccidioidomycosis. Oral azole therapy may be used primarily for less severe disease and for maintenance therapy. Without timely, appropriate treatment, many eyes will progress to requiring enucleation.

Suggested Reading

  1. Ampel NM. Coccidioidomycosis. In: Fauci AS, Braunweld E, Kasper DL, editors. Harrison’s Principles of Internal Medicine. New York: McGraw-Hill Book Company; 2008. p. 1247–9.Google Scholar
  2. Ampel NM. What’s behind the increasing rates of coccidioidomycosis in Arizona and California? Curr Inf Dis Rep. 2010;12:211–6.CrossRefGoogle Scholar
  3. Assi MA, Binnicker MJ, Wengenack NL, et al. Disseminated coccidioidomycosis in a liver transplant recipient with negative serology: use of polymerase chain reaction. Liver Transpl. 2006;12(8):1290–2.CrossRefPubMedGoogle Scholar
  4. Bell R, Font RL. Granulomatous anterior uveitis caused by Coccidioides immitis. Am J Ophthalmol. 1972;74(1):93–8.CrossRefPubMedGoogle Scholar
  5. Binnicker MJ, Buckwalter SP, Eisberner JJ, et al. Detection of Coccidioides species in clinical specimens by real-time PCR. J Clin Microbiol. 2007;45(1):173–8.CrossRefPubMedGoogle Scholar
  6. Blair JE. State-of-the-art treatment of coccidioidomycosis: skin and soft-tissue infections. Ann NY Acad Sci. 2007;1111:411–21.CrossRefPubMedGoogle Scholar
  7. Blumenkranz MS, Stevens DA. Endogenous coccidioidal endophthalmitis. Ophthalmology. 1980;87(10):974–84.CrossRefPubMedGoogle Scholar
  8. Bouza E, Dreyer JS, Hewitt WL. Coccidioidal meningitis. An analysis of thirty-one cases and review of the literature. Medicine (Baltimore). 1981;60:139–72.CrossRefGoogle Scholar
  9. Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol. 2005;139:135–40.CrossRefPubMedGoogle Scholar
  10. Catanzaro A, Galgiani JN, Levine BE, et al. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group. Am J Med. 1995;98:249–56.CrossRefPubMedGoogle Scholar
  11. Centers for Disease Control and Prevention (CDC). Increase in Coccidioidomycosis – California, 2000–2007. MMWR Morb Mortal Weekly Rep. 2009;58:105–9.Google Scholar
  12. Cheng ML, Leibowitz M, Ha E. Coccidioidal endophthalmitis in immunocompetent person, California, USA. Emerg Infect Dis. 2012;18(6):1015–6.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Cordeiro RA, Brilhante RS, Rocha MF, et al. In vitro activities of caspofungin, amphotericin B and azoles against Coccidiodes posadasii strains from Northeast Brazil. Mycopathologia. 2006;161:21–6.CrossRefPubMedGoogle Scholar
  14. Crum NF, Lederman ER, Stafford CM, et al. Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies. Medicine (Baltimore). 2004;83(3):149–75.CrossRefGoogle Scholar
  15. Crum-Cianflone NF. Voriconazole in combination with amphotericin B for salvage therapy of coccidioidomycosis. Infect Dis Clin Pract. 2007;15:265–8.CrossRefGoogle Scholar
  16. Cunningham ETJ, Seiff SR, Berger TG, Lizotte PE, Howes ELJ, Horton JC. Intraocular coccidioidomycosis diagnosed by skin biopsy. Arch Ophthalmol. 1998;116(5):674–7.CrossRefPubMedGoogle Scholar
  17. Dewsnup DH, Galgiani JN, Graybill JR, et al. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann Intern Med. 1996;124:305–10.CrossRefPubMedGoogle Scholar
  18. Fish DG, Ampel NM, Galgiani JN, et al. Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore). 1990;69:384–91.CrossRefGoogle Scholar
  19. Foos RY, Zakka KA. Coccidioidomycosis. In: Pepose JS, Holland GH, Wilhelmus KR, editors. Ocular infection and immunity. St. Louis: Mosby; 1996. p. 1430–6.Google Scholar
  20. Fusaro RM, Bansal S, Records RE. Some unusual periorbital dermatomes. Ann Ophthalmol. 1998;30:391–3.Google Scholar
  21. Gabrielian A, Hariprasad SM. New onset of bilateral multifocal coccidioioidomycosal choroiditis in a patient on oral fluconazole. Can J Ophthalmol. 2010;45:419–20.CrossRefPubMedGoogle Scholar
  22. Galgani JN. Coccidioidomycosis: changes in clinical expression, serological diagnosis, and therapeutic options. Clin Inf Dis. 2006;42:S100–5.CrossRefGoogle Scholar
  23. Galgiani JN, Cantazaro A, Cloud GA, et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. Ann Intern Med. 2000;133:676–86.CrossRefPubMedGoogle Scholar
  24. Granoff DM, Libke RD. Coccidioidomycosis. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. Philadelphia: WB Saunders; 1981. p. 1488–500.Google Scholar
  25. Hagele AJ, Evans DJ, Larwood TR. Primary endophthalmic coccidioidomycosis: report of a case of exogenous primary coccidioidomycosis of the eye diagnosed prior to enucleation. In: Aiello L, editor. Coccidioidomycosis: Papers from the Second Symposium. Tucson: University of Arizona Press; 1967. p. 37–9.Google Scholar
  26. Haque AK, McGinnis MR. Fungal Infections. In: Tomashefski JF Jr, Cagle PT, Farver CF, editors. Dail and Hammar’s Pulmonary Pathology. New York: Springer; 2008. p. 349–425.CrossRefGoogle Scholar
  27. Hirschmann JV. The early history of coccidioidomycosis: 1892-1945. Clin Infect Dis. 2007;44:1202–7.CrossRefPubMedGoogle Scholar
  28. Johnson RH, Einstein HE. Coccidioidal meningitis. Clin Inf Dis. 2006;42:103–7.CrossRefGoogle Scholar
  29. Lamer L, Paquin F, Lorange G, et al. Macular coccidioidomycosis. Can J Ophthalmol. 1982;17(3):121–3.PubMedGoogle Scholar
  30. Levitt JM. Ocular manifestations in coccidioidomycosis. Am J Ophthalmol. 1948;31:1626–8.CrossRefPubMedGoogle Scholar
  31. Luttrull JK, Wan WL, Kubak BM, et al. Treatment of ocular fungal infections with oral fluconazole. Am J Ophthalmol. 1995;119:477–81.CrossRefPubMedGoogle Scholar
  32. Maguire LJ, Campbell RJ, Edson RS. Coccidioidomycosis with necrotizing granulomatous conjunctivitis. Cornea. 1994;13:539–42.CrossRefPubMedGoogle Scholar
  33. Mark AS, Blake P, Atlas SW, et al. Gd-DTPA enhancement of the cisternal portion of the oculomotor nerve on MR imaging. Am J Neuroradiol. 1992;13:1463–70.PubMedGoogle Scholar
  34. Masannat FY, Ampel NM. Coccidioidomycosis in patients with HIV-1 infection in the era of potent antiretroviral therapy. Clin Infect Dis. 2010;50:1–7.CrossRefPubMedGoogle Scholar
  35. Mathisen G, Shelub A, Truong J. Coccidioidal meningitis: clinical presentation and management in the fluconazole era. Medicine (Baltimore). 2010;89:251–84.CrossRefGoogle Scholar
  36. Mondino KM, Holland GN, Glasgow BJ. Retinal seeding from anterior segment coccidioidomycosis after vitrectomy. Br J Ophthalmol. 2007;91:837–8.CrossRefPubMedPubMedCentralGoogle Scholar
  37. Moorthy RS, Rao NA, Sidikaro Y, Foos RY. Coccidioidomycosis iridocyclitis. Ophthalmology. 1994;101(12):1923–8.CrossRefPubMedGoogle Scholar
  38. O’Day DM, Foulds G, Williams TE, et al. Ocular uptake of fluconazole following oral administration. Arch Ophthalmol. 1990;108:1006–8.CrossRefPubMedGoogle Scholar
  39. Oldgfield ECIII, Bone WD, Martin CR, et al. Prediction of relapse after treatment of coccidioidomycosis. Clin Infect Dis. 1997;25:1205–10.CrossRefGoogle Scholar
  40. Parish JM, Blair JE. Mayo Clin Proc. 2008;83(3):343–8.CrossRefPubMedGoogle Scholar
  41. Pettit TH, Learn RN, Foos RY. Intraocular coccidioidomycosis. Arch Ophthalmol. 1967;77:655–61.CrossRefPubMedGoogle Scholar
  42. Proia LA, Tenorio AR. Successful use of voriconazole for treatment of Coccidioides meningitis. Antimicrob Agents Chemother. 2004;48:2341.CrossRefPubMedPubMedCentralGoogle Scholar
  43. Rixford E, Gilchrist TC. Two cases of protozoan (coccidioidal) infection of the skin and other organs. Johns Hopkins Hosp Rep. 1896;I:209–68.Google Scholar
  44. Rodenbiker HT, Ganley JP. Ocular coccidioidomycosis. Surv Ophthalmol. 1980;24(5):263–90.CrossRefPubMedGoogle Scholar
  45. Rodenbiker HT, Ganley JP, Galgiani JN, Axline SG. Prevalence of chorioretinal scars associated with coccidioidomycosis. Arch Ophthalmol. 1981;99(1):71–5.CrossRefPubMedGoogle Scholar
  46. Stevens DA. Coccidioidomycosis. N Engl J Med. 1995;332:1077–82.CrossRefGoogle Scholar
  47. Tamesis RR. Coccidioidomycosis. In: Foster CS, Vitale AT, editors. Diagnosis and treatment of uveitis. New Delhi: Jaypee Brothers Medical Publishers; 2013. p. 526–30.CrossRefGoogle Scholar
  48. Tsang CA, Tabnak F, Vugia DJ, Benedict K, Chiller T, Park BJ. Increase in reported coccidioidomycosis–United States, 1998–2011. MMWR Morb Mortal Weekly Rep. 2013;62(12):217–21.Google Scholar
  49. Vasconcelos-Santos DV, Lim JI, Rao NA. Chronic Coccidioidomycosis Endophthalmitis without concomitant systemic involvement: a clinicopathological case report. Ophthalmology. 2010;117:1839–42.CrossRefPubMedPubMedCentralGoogle Scholar
  50. Ventocilla M. Ocular Coccidioidomycosis. Medscape, 28 Jan 2015. Web, 25 Oct 2015. http://emedicine.medscape.com/article/1204191-overview.
  51. Vucicevic D, Blair JE, Binnicker MJ, et al. The utility of Coccidioides polymerase chain reaction testing in the clinical setting. Mycopathologia. 2010;170(5):345–51.CrossRefPubMedGoogle Scholar
  52. Warlick MA, Quan SF, Sobonya RE. Rapid diagnosis of pulmonary coccidioidomycosis. Cytologic v potassium hydroxide preparations. Arch Intern Med. 1983;143(4):723–5.CrossRefPubMedGoogle Scholar

Copyright information

© Springer (India) Pvt. Ltd. 2018

Authors and Affiliations

  1. 1.Vanderbilt Eye Institute, Department of Ophthalmology and Visual SciencesVanderbilt University School of MedicineNashvilleUSA
  2. 2.West Coast Retina Medical GroupSan FranciscoUSA

Personalised recommendations